| High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions JC Nault, M Mallet, C Pilati, J Calderaro, P Bioulac-Sage, C Laurent, ... Nature communications 4 (1), 2218, 2013 | 722 | 2013 |
| Immune and stromal classification of colorectal cancer is associated with molecular subtypes and relevant for precision immunotherapy E Becht, A de Reyniès, NA Giraldo, C Pilati, B Buttard, L Lacroix, J Selves, ... Clinical cancer research 22 (16), 4057-4066, 2016 | 574 | 2016 |
| Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours S Rebouissou, M Amessou, G Couchy, K Poussin, S Imbeaud, C Pilati, ... Nature 457 (7226), 200-204, 2009 | 540 | 2009 |
| Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas JC Nault, S Datta, S Imbeaud, A Franconi, M Mallet, G Couchy, E Letouzé, ... Nature genetics 47 (10), 1187-1193, 2015 | 524 | 2015 |
| Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation JC Nault, G Couchy, C Balabaud, G Morcrette, S Caruso, JF Blanc, ... Gastroenterology 152 (4), 880-894. e6, 2017 | 400 | 2017 |
| Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression S Rebouissou, A Franconi, J Calderaro, E Letouzé, S Imbeaud, C Pilati, ... Hepatology 64 (6), 2047-2061, 2016 | 282 | 2016 |
| Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation C Pilati, E Letouzé, JC Nault, S Imbeaud, A Boulai, J Calderaro, ... Cancer cell 25 (4), 428-441, 2014 | 279 | 2014 |
| Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas C Pilati, M Amessou, MP Bihl, C Balabaud, JT Van Nhieu, V Paradis, ... Journal of Experimental Medicine 208 (7), 1359-1366, 2011 | 278 | 2011 |
| Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas C Pilati, J Shinde, LB Alexandrov, G Assié, T André, Z Hélias‐Rodzewicz, ... The Journal of pathology 242 (1), 10-15, 2017 | 157 | 2017 |
| GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation JC Nault, M Fabre, G Couchy, C Pilati, E Jeannot, JT Van Nhieu, ... Journal of hepatology 56 (1), 184-191, 2012 | 142 | 2012 |
| A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy Z Saridaki, JB Weidhaas, HJ Lenz, P Laurent-Puig, B Jacobs, ... Clinical Cancer Research 20 (17), 4499-4510, 2014 | 76 | 2014 |
| CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification C Pilati, J Taieb, R Balogoun, L Marisa, A De Reyniès, P Laurent-Puig Annals of Oncology 28 (5), 1032-1035, 2017 | 75 | 2017 |
| STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model L Couronné, L Scourzic, C Pilati, V Della Valle, Y Duffourd, E Solary, ... Haematologica 98 (11), 1748, 2013 | 68 | 2013 |
| Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis RT Lawlor, N Veronese, A Pea, A Nottegar, L Smith, C Pilati, J Demurtas, ... BMC cancer 19, 1-7, 2019 | 63 | 2019 |
| Mutations leading to constitutive active gp130/JAK1/STAT3 pathway C Pilati, J Zucman-Rossi Cytokine & Growth Factor Reviews 26 (5), 499-506, 2015 | 60 | 2015 |
| PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications C Luchini, J Cros, A Pea, C Pilati, N Veronese, B Rusev, P Capelli, ... Human pathology 81, 157-165, 2018 | 52 | 2018 |
| Wild-type AAV insertions in hepatocellular carcinoma do not inform debate over genotoxicity risk of vectorized AAV JC Nault, I Mami, T La Bella, S Datta, S Imbeaud, A Franconi, M Mallet, ... Molecular Therapy 24 (4), 660-661, 2016 | 50 | 2016 |
| Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma K Poussin, C Pilati, G Couchy, J Calderaro, P Bioulac-Sage, Y Bacq, ... Oncoimmunology 2 (12), e27090, 2013 | 45 | 2013 |
| Intratumor CMS heterogeneity impacts patient prognosis in localized colon cancer L Marisa, Y Blum, J Taieb, M Ayadi, C Pilati, K Le Malicot, C Lepage, ... Clinical Cancer Research 27 (17), 4768-4780, 2021 | 43 | 2021 |
| Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis C Luchini, N Veronese, A Nottegar, M Cheng, T Kaneko, C Pilati, F Tabbò, ... Virchows Archiv 472, 939-947, 2018 | 39 | 2018 |
Jessica Zucman-RossiUniversité Paris Cité, AP-HPDirección de correo verificada de inserm.fr